Avanos Medical Inc. (AVNS)
15.10
0.05 (0.33%)
At close: Mar 03, 2025, 3:59 PM
15.13
0.20%
After-hours: Mar 03, 2025, 04:55 PM EST
Avanos Medical Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 107.7M | 87.7M | 127.7M | 118.5M | 111.5M | 205.3M | 384.5M | 219.7M | 113.7M | 129.5M | 149M | 44.1M | 47.9M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.1M | n/a | n/a |
| Other Long-Term Assets | 23.2M | 19.3M | 17.6M | 16.5M | 11.8M | 11.3M | 7.6M | 4.1M | 3.6M | 2M | 30.5M | 2.7M | 3.9M |
| Receivables | 132.8M | 142.8M | 167.9M | 118.2M | 167.9M | 163.8M | 150.5M | 203M | 188.5M | 224.7M | 233.9M | 203.3M | 183.7M |
| Inventory | 138.8M | 163.2M | 190.3M | 150.3M | 168.9M | 145.9M | 121.4M | 91.1M | 272.5M | 303.2M | 283.1M | 285.6M | 301.7M |
| Other Current Assets | 14.1M | 93.3M | 196.2M | 31.6M | 18.9M | 47M | 114.4M | 646.9M | 210.6M | 37.2M | 17.6M | 52.1M | 60.4M |
| Total Current Assets | 393.4M | 487M | 499.8M | 418.6M | 467.2M | 538.5M | 713.6M | 1.16B | 593.5M | 676M | 684.9M | 585.1M | 593.7M |
| Property-Plant & Equipment | 144.8M | 144M | 194.5M | 206.7M | 223.6M | 248.5M | 154.1M | 109.9M | 260.8M | 279.5M | 277.8M | 324.9M | 325.7M |
| Goodwill & Intangibles | 567.9M | 1.04B | 1.07B | 942.8M | 960.2M | 985.2M | 951.8M | 913.6M | 1.2B | 1.03B | 1.53B | 1.57B | 1.61B |
| Total Long-Term Assets | 760.8M | 1.21B | 1.29B | 1.18B | 1.21B | 1.26B | 1.12B | 1.04B | 1.48B | 1.32B | 1.84B | 1.9B | 1.94B |
| Total Assets | 1.15B | 1.69B | 1.79B | 1.59B | 1.67B | 1.8B | 1.83B | 2.2B | 2.07B | 2B | 2.53B | 2.48B | 2.53B |
| Account Payables | 54.3M | 56.3M | 67.9M | 56.4M | 67.6M | 83M | 169.9M | 171.2M | 160.6M | 163.2M | 168.7M | 118.5M | 102.2M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 144.9M | n/a | n/a | 23.4M | 12.2M | 20.7M |
| Short-Term Debt | 20.3M | 21.4M | 18.2M | 29.4M | 31M | 29.4M | n/a | 39.8M | n/a | n/a | 3.9M | -26M | 75.9M |
| Other Current Liabilities | 73.3M | 140.2M | 83.7M | 50.4M | 65M | 96.9M | 87.9M | 172M | 156.6M | 136.7M | 160M | 155.6M | 160.3M |
| Total Current Liabilities | 165.9M | 234.6M | 185.8M | 139.2M | 166.3M | 212.5M | 264.3M | 389.8M | 324.4M | 315.2M | 356M | 310.4M | 359.1M |
| Long-Term Debt | 149.9M | 187.7M | 258.8M | 172.8M | 233.3M | 310.7M | 247.7M | 541.1M | 579M | 578.1M | 632.3M | n/a | n/a |
| Other Long-Term Liabilities | 4.4M | 10M | 20.5M | 9.1M | 11M | 11.2M | 19.8M | 31.8M | 65.9M | 27.8M | 10.5M | 4M | 23M |
| Total Long-Term Liabilities | 159.8M | 221.5M | 309.9M | 191.5M | 250M | 321.9M | 271.9M | 590.7M | 644.9M | 629.7M | 680.4M | 94.5M | 119.4M |
| Total Liabilities | 325.7M | 456.1M | 495.7M | 330.7M | 416.3M | 534.4M | 536.2M | 980.5M | 969.3M | 944.9M | 1.04B | 404.9M | 478.5M |
| Total Debt | 170.2M | 209.1M | 280M | 187.5M | 248.8M | 325.4M | 247.7M | 580.9M | 579M | 578.1M | 636.2M | 11.9M | 75.9M |
| Common Stock | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 2.1B | 2.05B |
| Retained Earnings | -707M | -314.9M | -253.1M | -310.3M | -315.5M | -288.3M | -242.4M | -299.9M | -379.2M | -419M | 7.3M | n/a | n/a |
| Comprehensive Income | -44.6M | -27M | -35.8M | -33.8M | -28.1M | -32M | -33.7M | -31.3M | -50.1M | -43.2M | -19.1M | -19.6M | 10.1M |
| Shareholders Equity | 828.5M | 1.24B | 1.29B | 1.26B | 1.26B | 1.27B | 1.3B | 1.22B | 1.1B | 1.06B | 1.49B | 2.08B | 2.06B |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.1M | n/a | n/a |